Publications
5813 Results
- Journal / Conference
- CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Year
- 2023
- Research Committee(s)
- Prevention, Screening, and Surveillance, Prevention, Screening, and and Surveillance
- Study Number(s)
- S0000
Genome-wide Interaction Study with Smoking for Colorectal Cancer Risk Identifies Novel Genetic Loci Related to Tumor Suppression, Inflammation, and Immune Response
- Journal / Conference
- EUROPEAN UROLOGY
- Year
- 2023
- Research Committee(s)
- Cancer Control, Prevention, Screening, and Surveillance, Prevention, Screening, and and Surveillance
- PMID
- PMID36872133
- PMC
- PMC10424812
- Study Number(s)
- S0000, SWOG-9217
Evidence of Novel Susceptibility Variants for Prostate Cancer and a Multiancestry Polygenic Risk Score Associated with Aggressive Disease in Men of African Ancestry
- Journal / Conference
- JCO Precision Oncology
- Year
- 2023
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID37487150
- PMC
- PMC10581628
- Study Number(s)
- CTSU/C80405
Transcriptional Profiling and Consensus Molecular Subtype Assignment to Understand Response and Resistance to Anti-Epidermal Growth Factor Receptor Therapy in Colorectal Cancer
- Journal / Conference
- Br J Sports Med. Aug;57(15):965-971
- Year
- 2023
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID36878665
- PMC
- PMC19423490
- Study Number(s)
- CTSU/C80702
Association between physical activity and the time course of cancer recurrence in stage III colon cancer
- Journal / Conference
- CLINICAL CANCER RESEARCH
- Year
- 2023
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID37289007
- PMC
- PMC10524689
- Study Number(s)
- CTSU/C80702
Plasma 25-Hydroxyvitamin D Levels and Survival in Stage III Colon Cancer: Findings from CALGB/SWOG 80702 (Alliance)
- Journal / Conference
- Journal of Clinical Oncology 2023 Feb 1;41(4):803-815. doi: 10.1200/JCO.21.02726. Epub 2022 Oct 28.
- Year
- 2023
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID38547438
- Study Number(s)
- CTSU/C80702
Prognostic Impact of Early Treatment and Oxaliplatin Discontinuation in Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 11 Adjuvant Trials
- Journal / Conference
- Journal of Clinical Oncology
- Year
- 2023
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID36260828
- PMC
- PMC9995105
- Study Number(s)
- CTSU/E2211
Randomized Study of Temozolomide or Temozolomide and Capecitabine in Patients With Advanced Pancreatic Neuroendocrine Tumors (ECOG-ACRIN E2211)
- Journal / Conference
- Journal of Geriatric Oncology
- Year
- 2023
- Research Committee(s)
- Leukemia
- PMID
- PMID37329769
- Study Number(s)
- CTSU/A041202
Geriatric Assessment measures are predictive of outcomes in chronic lymphocytic leukemia
- Journal / Conference
- ASPO Annual Meeting (March 12-14, 2023, San Diego, CA)
- Year
- 2023
- Research Committee(s)
- Palliative Care
- Study Number(s)
- S1316
Ability to Eat among Cancer Patients Treated for Malignant Bowel Obstruction: A Secondary Analysis within SWOG S1316
- Journal / Conference
- St. Gallen International Breast Cancer Conference (March 15-18, 2023; St. Gallen, Switzerland), e-poster
- Year
- 2023
- Research Committee(s)
- Breast